Patent Foramen Ovale-Assessment and Treatment

Cardiovascular Therapeutics

Volumn 30, Issue 3, 2012, Pages

  Irwin, Bruce ^a   Ray, Simon ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cryptogenic stroke; Migraine; Patent foramen ovale

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANTICOAGULANT THERAPY; BRAIN EMBOLISM; DECOMPRESSION SICKNESS; DEMENTIA; DISEASE ASSOCIATION; DYSPNEA; HUMAN; HYPOXEMIA; MEDICAL INSTRUMENTATION; MIGRAINE WITH AURA; PATENT FORAMEN OVALE; PLATYPNEA ORTHODEOXIA SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VEIN THROMBOSIS;

CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MIGRAINE DISORDERS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEPTAL OCCLUDER DEVICE; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84860628723     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00250.x     Document Type: Review

References (74)

1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
2. Hart SA, Krasuski RA. Incidence of asymptomatic patent foramen ovale according to age. Ann Int Med 2009;150:431-423.
3. Sastry S, Daly KJ, Chengodu T, McCollum CN. Is the contrast transcranial Doppler test for venous-to-arterial circulation shunts reproducible? Cerebrovasc Dis 2007;23:424-429.
4. Pinto FJ. When and how to diagnose patent foramen ovale. Heart 2005;91:438-440.
5. Van Camp G, Franken P, Melis P, Cosyns B, Schoors D, Vanoverschelde JL. Comparison of transthoracic echocardiography with second harmonic imaging with transesophageal echocardiography in the detection of right to left shunts. Am J Cardiol 2000;86:1284-1287.
6. Trevelyan J, Steeds RP. Comparison of transthoracic echocardiography with harmonic imaging with transoesophageal echocardiography for the diagnosis of patent foramen ovale. Postgrad Med J. 2006;82:613-614.
7. Thanigaraj S, Valika A, Zajarias A, Lasala JM, Perez JE. Comparison of transthoracic versus transesophageal echocardiography for detection of right-to-left atrial shunting using agitated saline contrast. Am J Cardiol 2005;96:1007-1010.
8. Hamann GF, Schätzer-Klotz D, Fröhlig G, et al. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology 1998;50:1423-1428.
9. Gin KG, Huckell VF, Pollick C. Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale. J Am Coll Cardiol 1993;22:1994-2000.
10. Sacco RL, Elllenberg JH, Mohr JP, et al. Infarcts of undetermined cause: The NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-390.
11. Poppert H, Morschhaeuser M, Feurer R, et al. Lack of association between right-to-left shunt and cerebral ischemia after adjustment for gender and age. J Negat Results Biomed 2008;7:7.
12. Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81:602-608.
13. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case control studies. Neurology 2000;55:1172-1174.
14. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Eng J Med 2007;357:2262-2268.
15. Cramer SC, Rordorf G, Maki JH, et al. Increased Pelvic Vein Thrombi in Cryptogenic Stroke. Results of the Paradoxical Emboli From Large Veins in Ischemic Stroke (PELVIS) Study. Stroke 2004;35:46-50.
16. Rigatelli G, Aggio S, Cardaioli P, et al. Left Atrial Dysfunction in Patients With Patent Foramen Ovale and Atrial Septal Aneurysm: An Alternative Concurrent Mechanism for Arterial Embolism? J Am Coll Cardiol Intv 2009;2:655-662.
17. Bonvini RF, Sztajzel R, Dorsaz PA, et al. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke. Int J Stroke 2010;5:4-9.
18. Burow A, Schwerzmann M, Wallmann D, et al. Atrial fibrillation following device closure of patent foramen ovale. Cardiology 2008;111:47-50.
19. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent Foramen Ovale in Cryptogenic Stroke Incidental or Pathogenic? Stroke 2009;40:2349-2355.
20. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent Foramen Ovale and the Risk of Ischemic Stroke in a Multiethnic Population. J Am Coll Cardiol 2007;49:797-802.
21. Meissner I, Khandheria BK, Heit JA, et al. Patent Foramen Ovale: Innocent or Guilty? Evidence From a Prospective Population-Based Study. J Am Coll Cardiol 2006;47:440-445.
22. Ford MA, Reeder GS, Lennon RJ, et al. Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack: The Mayo Clinic experience. J Am Coll Cardiol Intv 2009;2:404-411.
23. Mas J-L, Arquizan C, Lamy C, et al. Recurrent Cerebrovasular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both. N Engl J Med 2001;345:1740-1746.
24. Goel SS, Tuzcu EM, Shishehbor MH, et al. Morphology of the Patent Foramen Ovale in Asymptomatic Versus Symptomatic (Stroke or Transient Ischemic Attack) Patients. Am J Cardiol 2009;103:124-129.
25. De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413.
26. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, for the PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in cryptogenic stroke study. Circulation 2002;105:2625-2631.
27. Serena J, Marti-Fàbregas J, Santamarina E, et al. Recurrent Stroke and Massive Right-to-Left Shunt Results From the Prospective Spanish Multicenter (CODICIA) Study. Stroke 2008;39:3131-3136.
28. Karttunena V, Hiltunenb L, Rasib V, Vahterab E, Hillbom M. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 2003;14:261-268.
29. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WB, Lorenzetti DL, Hill MD. Recurrent cerebral iscaemic in medically treated patent foramen ovale. Neurology 2009;73:89-97.
30. Krasuski RA, Hart SA, Allen D, et al. Prevalence and Repair of Intraoperatively Diagnosed Patent Foramen Ovale and Association With Perioperative Outcomes and Long-term Survival. JAMA 2009;302:290-297.
31. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli- A systematic review. Ann Intern Med 2003;139:753-760.
32. Homma S, Sacco RL. Patent Foramen Ovale and Stroke. Circulation 2005;112:1063-1072.
33. Whorle J. Closure of patent foramen ovale after cryptogenic stroke. Lancet 2006;368:350-352.
34. Benbassata J, Baumal R. Variability in duration of follow up may bias the conclusions of cohort studies of patients with patent foramen ovale. Eur J Neurol 2008;15:909-915.
35. Wahl A, Tai T, Praz F, et al. Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography: Effect of Device Size. J Am Coll Cardiol Intv 2009;2:116-123.
36. Opotowsky AR, Landzberg MJ, Kimmel SE, Webb GD. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: The impact of clinical variables and hospital procedure volume on in-hospital adverse events. Am Heart J 2009;157:867-874.
37. Schoen SP, Boscheri A, Lange SA, Braun MU, Fuhrmann J, Kappert U, Strasser RH. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale. Heart 2008;94:844-847.
38. Wöhrle J, Kochs M, Spiess J, Nusser T, Hombach V, Merkle N. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies. Circulation 2009;119:3002-3008.
39. Staubach S, Steinberg DH, Zimmermann W, Wawra N, Wilson N, Wunderlich N, Sievert H. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv 2009;74:889-895.
40. Alaeddini J, Feghali G, Jenkins S, Ramee S, White C, Abi-Samra F. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. J Invasive Cardiol 2006;18:365-368.
41. Harms V, Reisman M, Fuller CJ, et al. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Am J Cardiol 2007;99:1312-1315.
42. Messe SR, Silverman IE, Kizer JR, et al. Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;62:1042-1050.
43. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for Ischemic Stroke. Chest 2004;126:483S-512S.
44. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. A statement for healthcare professionals from the american heart association/american stroke association council on stroke. Stroke 2006;37:577-617.
45. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
46. O'Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: A call for completion of randomized clinical trials a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2009;53:2014-2018.
47. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
48. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: A quantitative systematic review. Cephalalgia 2008;28:531-540.
49. Garg P, Servoss SJ, Wu JC, et al. Lack of association between migraine headache and patent foramen ovale: Results of a case-control study. Circulation 2010;121:1406-1412.
50. Rundek T, Elkind MSV, Di Tullio MR, et al. Patent Foramen Ovale and Migraine A Cross-Sectional Study From the Northern Manhattan Study (NOMAS). Circulation 2008;118:1419-1424.
51. Wilmshurst PT, Nightingale S. The role of cardiac and pulmonary pathology in migraine: A Hypothesis. Headache 2006;46:429-434.
52. Anzola GP, Meneghetti G, Zanferrari C, Adami A, Dinia L, Del Sette M for the SAM Study Group. Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia 2008;28:360-366.
53. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relationship to familial migraine with aura. Heart 2004;90:1315-1320.
54. Vigna C, Marchese N, Inchingolo V, et al. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions a case-control study. J Am Coll Cardiol Intv 2009;2:107-113.
55. Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with starflex technology (mist) trial a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with starflex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404.
56. Carroll JD. Migraine intervention with starflex technology trial a controversial trial of migraine and patent foramen ovale closure. Circulation 2008;117:1358-1360.
57. Torti SR, Billinger M, Schwerzmann M, et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004;25:1014-1020.
58. Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001;134:21-24.
59. Schnabel TG, Ratto O, Kirby CK, Johnson J, Comroe JH. Postural cyanosis and angina pectoris following pneumonectomy: Relief by closure of an interatrial septum defect. J Thorac Surg 1956;32:246-250.
60. Eicher J-C, Bonniaud P, Baudouin N, et al. Hypoxaemia associated with an enlarged aortic root: A new syndrome? Heart 2005;9:1030-1035.
61. Kubler P, Gibbs, H, Garrahy P. Platypnoea-orthodeoxia syndrome. Heart 2000;83:221-223.
62. Diaz Castro O, Bueno H, Nebreda LA. Acute myocardial infarction caused by paradoxical tumorous embolism as a manifestation of hepatocarcinoma. Heart 2004;90:e29.
63. Agostoni P, Gasparini G, Destro G. Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman. Heart 2004;90:e12.
64. Steiger BW, Libanoff AJ, Springer EB. Myocardial infarction due to paradoxical embolism. Am J Med 1969;47:995-998.
65. Sastry S, Riding G, Morris J, Taberner D, Cherry N, Heagerty A, McCollum C. Young adult myocardial infarction and ischemic stroke the role of paradoxical embolism and thrombophilia (the yamis study). J Am Coll Cardiol 2006;48:686-691.
66. Crump R, Shandling AH, Van Natta B, Ellestad M. Prevalence of patent foramen ovale in patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 2000;85:1368-1370.
67. Iguchi Y, Kimura K, Kobayashi K, Tachi T, Aihara T, Harada T. Sudden deafness and right-to-left shunts. Cerebrovasc Dis 2008;26:409-412.
68. Hashimoto Y, Terasaki T, Hara Y, Furuyoshi N, Uchino M. Etiological studies on 17 cases of retinal artery occlusion and 16 cases of amaurosis fugax. Rinsho Shinkeigaku 1998;38:219-223.
69. Hofbauer LC, Schmauss S, Fuchshuber S, Danek A, Heufelder AE. Lacunar cerebral infarction in a young woman. Dtsch Med Wochenschr 1995;120:1777-1782.
70. Wada Y, Takahashi R, Yanagihara C, Nishimura Y. Paradoxical cerebral embolism as the initial symptom in a patient with ovarian cancer. J Stroke Cerebrovasc Dis 2007;16:88-90.
71. Daly KJ, Pearse A, Nasim A, Ray SG, McCollum CN. Paradoxical embolism in peripheral ishaemia: Diagnosis of venous to arterial shunting by transcranial Doppler. Eur J Endovasc Surg 2003;26:219-220.
72. Kivipelto M, Solomon A. Cerebral embolism and Alzheimer's disease. BMJ 2006;332:1104-1105.
73. Purandare N, Burns A, Daly KJ, et al. Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: Case-control study. BMJ 2006;332:1119-1124.
74. Purandare N, Voshaar RCO, McCollum C, Jackson A, Burns A. Paradoxical embolisation and cerebral white matter lesions in dementia. Br J Radiol 2008;81:30-33.